ImmunologybioRxivPreprint
Peptide:MHC dependent activation of natural killer cells through KIR2DS2 generates anti-tumor responses
P. Rettman, M. D. Blunt, B. Mbiribindi…·S. I. Khakoo
This study shows that activating NK cells via KIR2DS2 with a peptide:MHC vaccine generates anti-tumor responses and identifies XPO1 as a cancer-associated ligand for KIR2DS2.
DOI 10.1101/2020.04.15.042077